✉news ScienceBiology first seen 9 h ago, last 59 min ago, peak #13
B7-33 and the Expanding Frontier of Biased Ligand Research
The peptide B7-33, a biased ligand studied for its potential to deliver the therapeutic benefits of the H2 relaxin hormone without unwanted side effects, is drawing attention as research into biased signaling expands. Scientists hope such compounds can activate only beneficial cellular pathways, opening new directions in drug development for fibrosis and cardiovascular conditions.
Why now: Growing interest in biased ligands as a promising new approach to safer, more targeted drug design.
Rank over time, top of the chart is #1. 7 snapshots from 9 h ago to 59 min ago.
Evidence
- B7-33 and the Expanding Frontier of Biased Ligand Research · Tifton Gazette
API: https://socialmediatrends-api.osmike.com/v1/trends/635973